The Journal of clinical endocrinology and metabolism
The most recent articles from:
April 2010
-
J. Clin. Endocrinol. Metab. · Apr 2010
Randomized Controlled TrialEffects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.
Teriparatide increases both bone formation and bone resorption. ⋯ Alendronate reduces the ability of teriparatide to increase BMD and bone turnover in women.